Exercise and the Treatment of Diabetes and Obesity

Endocrinology and Metabolism Clinics of North America

Volumn 37, Issue 4, 2008, Pages 887-903

  O'Gorman, Donal J ^a   Krook, Anna ^b  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

AMPK; Exercise; Gene expression; Insulin resistance; Skeletal muscle; Substrate metabolism

Indexed keywords

ADENYLATE KINASE; FATTY ACID; GLUCOSE; INSULIN; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL;

CARBOHYDRATE METABOLISM; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; ENERGY EXPENDITURE; EXERCISE PHYSIOLOGY; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; GLUCOSE OXIDATION; HEALTH PROGRAM; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; KINESIOTHERAPY; LIFESTYLE MODIFICATION; LIPID METABOLISM; LIPID PEROXIDATION; METABOLIC DISORDER; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MUSCLE CONTRACTION; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SKELETAL MUSCLE; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT REDUCTION;

ANIMALS; DIABETES MELLITUS; EXERCISE; EXERCISE THERAPY; GENE EXPRESSION REGULATION; GENETIC VARIATION; HUMANS; MUSCLE CONTRACTION; MUSCLE, SKELETAL; OBESITY;

EID: 56549093005     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2008.07.006     Document Type: Review

References (138)

1. Pedersen B.K. Body mass index-independent effect of fitness and physical activity for all-cause mortality. Scand J Med Sci Sports 17 (2007) 196-204
2. Booth F.W., Chakravarthy M.V., Gordon S.E., et al. Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy. J Appl Physiol 93 (2002) 3-30
3. Adams S.A., Der Ananian C.A., DuBose K.D., et al. Physical activity levels among overweight and obese adults in South Carolina. South Med J 96 (2003) 539-543
4. Wei M., Kampert J.B., Barlow C.E., et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA 282 (1999) 1547-1553
5. Iyawe V.I., Ighoroje A.D., and Iyawe H.O. Changes in blood pressure and serum cholesterol following exercise training in Nigerian hypertensive subjects. J Hum Hypertens 10 (1996) 483-487
6. Despres J.P., and Lamarche B. Low-intensity endurance exercise training, plasma lipoproteins and the risk of coronary heart disease. J Intern Med 236 (1994) 7-22
7. Boule N.G., Haddad E., Kenny G.P., et al. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 86 (2001) 1218-1227
8. Kirwan J.P., del Aguila L.F., Hernandez J.M., et al. Regular exercise enhances insulin activation of IRS-1-associated PI3-kinase in human skeletal muscle. J Appl Physiol 88 (2000) 797-803
9. Steiner S., Niessner A., Ziegler S., et al. Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease. Atherosclerosis 181 (2005) 305-310
10. Bergström K., Barany P., and Holm I. An educational programme for persistent life-style changes in patients with chronic renal disease. EDTNA ERCA J 25 (1999) 42-44
11. Dela F., Mikines K.J., von Linstow M., et al. Effect of training on insulin-mediated glucose uptake in human muscle. Am J Physiol 263 (1992) E1134-E1143
12. King D.S., Dalsky G.P., Staten M.A., et al. Insulin action and secretion in endurance-trained and untrained humans. J Appl Physiol 63 (1987) 2247-2252
13. O'Gorman D.J., Karlsson H.K.R., McQuaid S., et al. Exercise training increases insulin-stimulated glucose disposal and GLUT4 (SLC2A4) protein content in patients with type 2 diabetes. Diabetologia 49 (2006) 2983-2992
14. Eriksson J., Lindström J., Valle T., et al. Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetoloiga 42 (1999) 793-801
15. Eriksson K., and Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise: the 6-year Malmö feasibility study. Diabetologia 34 (1991) 891-898
16. X P., Li G., Hu Y., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20 (1997) 537-544
17. Tuomilehto J., Lindstrom J., Eriksson J.G., et al. Prevention of Type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344 (2001) 1343-1350
18. Uusitupa M.I. Early lifestyle intervention in patients with non-insulin-dependent diabetes mellitus and impaired glucose tolerance. Annu Mediaev 28 (1996) 445-449
19. Hamdy O., Goodyear L.J., and Horton E.S. Diet and exercise in type 2 diabetes mellitus. Endocrinol Metab Clin North Am 30 (2001) 883-907
20. Ligtenberg P.C., Hoekstra J.B.L., Bol E., et al. Effects of physical training on metabolic control in elderly type 2 diabetes mellitus patients. Clin Sci (Colch) 93 (1997) 127-135
21. Skarfors E.T., Wegener T.A., Lithell H., et al. Physical training as treatment for type 2 (non-insulin-dependent) diabetes in elderly men. A feasibility study over 2 years. Diabetologia 30 (1987) 930-933
22. Krook A., Holm I., Pettersson S., et al. Reduction of risk factors following lifestyle modification programme in subjects with type 2 (non-insulin dependent) diabetes mellitus. Clin Physiol Funct Imaging 23 (2003) 21-30
23. Holloszy J.O., and Booth F.W. Biochemical adaptations to endurance exercise in muscle. Annu Rev Physiol 38 (1976) 273-291
24. Bruce C.R., Lee J.S., and Hawley J.A. Postexercise muscle glycogen resynthesis in obese insulin-resistant Zucker rats. J Appl Physiol 91 (2001) 1512-1519
25. Price T.B., Rothman D.L., Taylor R., et al. Human muscle glycogen resynthesis after exercise: insulin-dependent and -independent phases. J Appl Physiol 76 (1994) 104-111
26. Greiwe J.S., Hickner R.C., Hansen P.A., et al. Effects of endurance exercise training on muscle glycogen accumulation in humans. J Appl Physiol 87 (1999) 222-226
27. Goodpaster B.H., Katsiaras A., and Kelley D.E. Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes 52 (2003) 2191-2197
28. DiPietro L., Dziura J., Yeckel C.W., et al. Exercise and improved insulin sensitivity in older women: evidence of the enduring benefits of higher intensity training. J Appl Physiol 100 (2006) 142-149
29. Romijn J.A., Klein S., Coyle E.F., et al. Strenuous endurance training increases lipolysis and triglyceride-fatty acid cycling at rest. J Appl Physiol 75 (1993) 108-113
30. Klein S., Coyle E.F., and Wolfe R.R. Fat metabolism during low-intensity exercise in endurance-trained and untrained men. Am J Physiol 267 (1994) E934-E940
31. Horowitz J.F., and Klein S. Lipid metabolism during endurance exercise. Am J Clin Nutr 72 (2000) 558S-563S
32. Smekal G., von Duvillard S.P., Pokan R., et al. Effect of endurance training on muscle fat metabolism during prolonged exercise: agreements and disagreements. Nutrition 19 (2003) 891-900
33. Hurley B.F., Nemeth P.M., Martin III W.H., et al. Muscle triglyceride utilization during exercise: effect of training. J Appl Physiol 60 (1986) 562-567
34. Larson-Meyer D.E., Newcomer B.R., and Hunter G.R. Influence of endurance running and recovery diet on intramyocellular lipid content in women: a 1H NMR study. Am J Physiol Endocrinol Metab 282 (2002) E95-106
35. Douen A.G., Ramlal T., Rastogi S.A., et al. Exercise induces recruitment of the "insulin responsive" glucose transporter. Evidence for distinct intracellular insulin- and exercise-recruitable transporter pools in skeletal muscle. J Biol Chem 265 (1990) 13427-13430
36. Kristiansen S., Hargreaves M., and Richter E.A. Exercise-induced increase in glucose transport, GLUT-4, and VAMP-2 in plasma membrane from human muscle. Am J Physiol Endocrinol Metab 270 (1996) E197-81
37. Lund S., Holman G.D., Schmitz O., et al. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci U S A 92 (1995) 5817-5821
38. Zierath J.R. Exercise effects of muscle insulin signaling and action: invited review: exercise training-induced changes in insulin signaling in skeletal muscle. J Appl Physiol 93 (2002) 773-781
39. Long Y.C., and Zierath J.R. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 116 (2006) 1776-1783
40. Kelley D.E., Mintun M.A., Watkins S.C., et al. The Effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest 97 (1996) 2705-2713
41. Kelley D.E., and Simoneau J.-A. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 94 (1994) 2349-2356
42. Zierath J.R. In vitro studies of human skeletal muscle. hormonal and metabolic regulation of glucose transport. Acta Physiol Scand 155 (1995) 1-96
43. Zierath J.R., He L., Guma A., et al. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 39 (1996) 1180-1189
44. Krook A., Björnholm M., Jiang X.-J., et al. Characterization of signal transduction and glucose transport in skeletal muscle from Type 2 (non-insulin-dependent) diabetic patients. Diabetes 49 (2000) 284-292
45. Shulman G.I., Rothman D.L., Jue T., et al. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322 (1990) 223-228
46. Goodpaster B.H., Theriault R., Watkins S.C., et al. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 49 (2000) 467-472
47. Blaak E.E., Wagenmakers A.J.L., Glatz J.F.C., et al. Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab 279 (2000) E146-E154
48. Mittendorfer B., Fields D.A., and Klein S. Excess body fat in men decreases plasma fatty acid availability and oxidation during endurance exercise. Am J Physiol Endocrinol Metab 286 (2004) E354-E362
49. Goodpaster B.H., Wolfe R.R., and Kelley D.E. Effects of obesity on substrate utilization during exercise. Obes Res 10 (2002) 575-584
50. Numao S., Hayashi Y., Katayama Y., et al. Effects of obesity phenotype on fat metabolism in obese men during endurance exercise. Int J Obes 8 (2006) 1189-1196
51. van Aggel-Leijssen D.P., Saris W.H., Wagenmakers A.J., et al. The effect of low-intensity exercise training on fat metabolism of obese women. Obes Res 9 (2001) 86-96
52. Braun B., Sharoff C., Chipkin S.R., et al. Effects of insulin resistance on substrate utilization during exercise in overweight women. J Appl Physiol 97 (2004) 991-997
53. van Aggel-Leijssen D.P., Saris W.H., Wagenmakers A.J., et al. Effect of exercise training at different intensities on fat metabolism of obese men. J Appl Physiol 92 (2002) 1300-1309
54. Menshikova E.V., Ritov V.B., Toledo F.G., et al. Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity. Am J Physiol Endocrinol Metab 288 (2005) E818-E825
55. Menshikova E.V., Ritov V.B., Ferrell R.E., et al. Characteristics of skeletal muscle mitochondrial biogenesis induced by moderate-intensity exercise and weight loss in obesity. J Appl Physiol 103 (2007) 21-27
56. Ritov V.B., Menshikova E.V., He J., et al. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 54 (2005) 8-14
57. Malenfant P., Tremblay A., Doucet E., et al. Elevated intramyocellular lipid concentration in obese subjects is not reduced after diet and exercise training. Am J Physiol Endocrinol Metab 280 (2001) E632-E639
58. Burns N., Finucane F.M., Hatunic M., et al. Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in beta cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training. Diabetologia 50 (2007) 1500-1508
59. Giacca A., Groenewoud Y., Tsui E., et al. Glucose production, utilization, and cycling in response to moderate exercise in obese subjects with type 2 diabetes and mild hyperglycemia. Diabetes 47 (1998) 1763-1770
60. Kang J., Kelley D.E., Robertson R.J., et al. Substrate utilization and glucose turnover during exercise of varying intensities in individuals with NIDDM. Med Sci Sports Exerc 31 (1999) 82-89
61. Dela F., Larsen J.J., Mikines K.J., et al. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training. Diabetes 44 (1999) 1010-1020
62. Perseghin G., Price T.B., Petersen K.F., et al. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med 335 (1996) 1357-1362
63. Cline G.W., Petersen K.F., Krssak M., et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341 (1999) 240-246
64. Krook A., Wallberg-Henriksson H., and Zierath J.R. Sending the signal: molecular mechanisms regulating glucose uptake. Med Sci Sports Exerc 36 (2004) 1212-1217
65. Krook A., Bjornholm M., Galuska D., et al. Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 49 (2000) 284-292
66. Petersen K.F., Dufour S., Befroy D., et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350 (2004) 664-671
67. Simoneau J.A., and Kelley D.E. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 83 (1997) 166-171
68. Kelley D.E., He J., Menshikova E.V., et al. Dysfunction of mitochondria in human skeletal muscle in Type 2 diabetes. Diabetes 51 (2002) 2944-2950
69. Lowell B.B., and Shulman G.I. Mitochondrial dysfunction and type 2 diabetes. Science 307 (2005) 384-387
70. Chibalin A.V., Leng Y., Vieira E., et al. Down-Regulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance. Cell 132 (2008) 375-386
71. Fritz T., Krämer D.K., Karlsson H.K.R., et al. Low-intensity exercise increases skeletal muscle protein expression of PPAR delta and UCP3 in type 2 diabetic patients. Diabetes Metab Res Rev 22 (2006) 492-498
72. Teran-Garcia M., Rankinen T., Koza R.A., et al. Endurance training-induced changes in insulin sensitivity and gene expression. Am J Physiol Endocrinol Metab 288 (2005) E1168-E1178
73. Simoneau J.-A., and Kelley D.E. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 83 (1997) 166-171
74. Holloszy J.O., and Coyle E.F. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol 56 (1984) 831-838
75. Dudley G.A., Abraham W.M., and Terjung R.L. Influence of exercise intensity and duration on biochemical adaptations in skeletal muscle. J Appl Physiol 53 (1982) 844-850
76. Toledo F.G., Watkins S., and Kelley D.E. Changes induced by physical activity and weight loss in the morphology of intermyofibrillar mitochondria in obese men and women. J Clin Endocrinol Metab 91 (2006) 3224-3227
77. Chibalin A.V., Yu M., Ryder J.W., et al. Exercise-induced changes in expression and activity of proteins involved in insulin-signal-transduction in skeletal muscle: differential effects on IRS-1 and IRS-2. Proc Natl Acad Sci U S A 97 (2000) 38
78. Houmard J.A., Egan P.C., Neufer P.D., et al. Elevated skeletal muscle glucose transporter levels in exercise-trained middle-aged men. Am J Physiol 261 (1991) E437-E443
79. Hughes V.A., Fiatarone M.A., Fielding R.A., et al. Exercise increases muscle GLUT4-levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol 264 (1993) E855-E862
80. Ploug T., Stallknecht B.M., Pedersen O., et al. Effect of endurance training on glucose transport capacity and glucose transporter expression in rat skeletal muscle. Am J Physiol 259 (1990) E778-E786
81. Ren J.-M., Semenkovich C.F., Gulve E.A., et al. Exercise induces rapid increases in GLUT4 expression, glucose transport capacity, and insulin-stimulated glycogen storage in muscle. J Biol Chem 269 (1994) 14396-14401
82. Yu M., Blomstrand E., Chibalin A.V., et al. Exercise-associated differences in an array of proteins involved in signal transduction and glucose transport. J Appl Physiol 90 (2001) 29-34
83. Horowitz J.F., Leone T.C., Feng W., et al. Effect of endurance training on lipid metabolism in women: a potential role for PPARalpha in the metabolic response to training. Am J Physiol Endocrinol Metab 279 (2000) E348-E355
84. Tunstall R.J., Mehan K.A., Wadley G.D., et al. Exercise training increases lipid metabolism gene expression in human skeletal muscle. Am J Physiol Endocrinol Metab 283 (2002) E66-E72
85. Maassen J.A., t Hart L.M., Janssen G.M., et al. Mitochondrial diabetes and its lessons for common Type 2 diabetes. Biochem Soc Trans 34 (2006) 819-823
86. Freyer C., and Larsson N. Is Energy Deficiency Good in Moderation?. Cell 131 (2007) 448-450
87. Bergeron R., Ren J.M., Cadman K.S., et al. Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab 281 (2001) E1340-E1346
88. Ojuka E.O., Jones T.E., Han D.H., et al. Raising Ca2+ in L6 myotubes mimics effects of exercise on mitochondrial biogenesis in muscle. FASEB J 17 (2003) 675-681
89. Handschin C., Rhee J., Lin J., et al. An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. PMID 100 (2003) 7111-6
90. Wu H., Kanatous S.B., Thurmond F.A., et al. Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 296 (2002) 349-352
91. Rose A.J., and Hargreaves M. Exercise increases Ca2+-calmodulin-dependent protein kinase II activity in human skeletal muscle. J Physiol 553 (2003) 303-309
92. Zong H., Ren J.M., Young L.H., et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. PMID 99 (2002) 15983-7
93. McGee S.L., Howlett K.F., Starkie R.L., et al. Exercise increases nuclear AMPK alpha2 in human skeletal muscle. Diabetes 52 (2003) 926-928
94. Winder W.W., Holmes B.F., Rubink D.S., et al. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 88 (2000) 2219-2226
95. Jager S., Handschin C., St-Pierre J., et al. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. PMID 104 (2007) 12017-12022
96. Wu Z., Puigserver P., Andersson U., et al. Mechnisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98 (1999) 115-124
97. Lin J., Handschin C., and Spiegelman B.M. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1 (2005) 361-370
98. Crunkhorn S., Dearie F., Mantzoros C., et al. Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. J Biol Chem 282 (2007) 15439-15450
99. Mootha V.K., Lindgren C.M., Eriksson K.F., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34 (2003) 267-273
100. Patti M.E., Butte A.J., Crunkhorn S., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. PNAS 100 (2003) 8466-8471
101. Benton C.R., Han X.X., Febbraio M., et al. Inverse relationship between PGC-1alpha protein expression and triacylglycerol accumulation in rodent skeletal muscle. J Appl Physiol 100 (2006) 377-383
102. Lin J., Wu H., Tarr P.T., et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418 (2002) 797-801
103. Wang Y.X., Zhang C.L., Yu R.T., et al. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2 (2004) e294
104. Kannisto K., Chibalin A., Glinghammar B., et al. Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise. Int J Mol Med 17 (2006) 45-52
105. Russell A.P., Hesselink M.K., Lo S.K., et al. Regulation of metabolic transcriptional co-activators and transcription factors with acute exercise. FASEB J 19 (2005) 986-988
106. Watt M.J., Southgate R.J., Holmes A.G., et al. Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes. J Mol Endocrinol 33 (2004) 533-544
107. Baar K., Wende A.R., Jones T.E., et al. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J 16 (2002) 1879-1886
108. Cartoni R., Leger B., Hock M.B., et al. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J Physiol 567 (2005) 349-358
109. Mahoney D.J., Parise G., Melov S., et al. Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise. FASEB J 19 (2005) 1498-1500
110. Pilegaard H., Osada T., Andersen L.T., et al. Substrate availability and transcriptional regulation of metabolic genes in human skeletal muscle during recovery from exercise. Metab Clin Exp 54 (2005) 1048-1055
111. Vissing K., Andersen J.L., and Schjerling P. Are exercise-induced genes induced by exercise?. FASEB J 19 (2005) 94-96
112. Pilegaard H., Saltin B., and Neufer P.D. Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle. J Physiol 546 (2003) 851-858
113. Russell A.P., Feilchenfeldt J., Schreiber S., et al. Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle. Diabetes 52 (2003) 2874-2881
114. Short K.R., Vittone J.L., Bigelow M.L., et al. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 52 (2003) 1886-86
115. Garnier A., Fortin D., Zoll J., et al. Coordinated changes in mitochondrial function and biogenesis in healthy and diseased human skeletal muscle. FASEB J 19 (2005) 43-52
116. Norrbom J., Sundberg C.J., Ameln H., et al. PGC-1alpha mRNA expression is influenced by metabolic perturbation in exercising human skeletal muscle. J Appl Physiol 96 (2004) 189-194
117. Naya F.J., Mercer B., Shelton J., et al. Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. J Biol Chem 275 (2000) 4545-4548
118. Oh M., Rybkin I.I., Copeland V., et al. Calcineurin Is necessary for the maintenance but not embryonic development of slow muscle fibers. Mol Cell Biol 25 (2005) 6629-6638
119. Ryder J.W., Bassel-Duby R., Olson E.N., et al. Skeletal muscle reprogramming by activation of calcineurin improves insulin action on metabolic pathways. J Biol Chem 278 (2003) 44298-44304
120. Schiaffino S., and Serrano A. Calcineurin signaling and neural control of skeletal muscle fiber type and size. Trends Pharmacol Sci 23 (2002) 569-575
121. Saltin B., Henriksson J., Nygaard E., et al. Fiber types and metabolic potentials of skeletal muscles in sedentary man and endurance runners. Ann NY Acad Sci 301 (1977) 3-29
122. Aksnes A.K., Hjeltnes N., Wahlstrom E.O., et al. Intact glucose transport in morphologically altered denervated skeletal muscle from quadriplegic patients. Am J Physiol 271 (1996) E593-E600
123. Grimby G., Broberg C., Krotkiewska I., et al. Muscle fiber composition in patients with traumatic cord lesion. Scand J Rehabil Med 8 (1976) 37-42
124. Kramer D.K., Ahlsen M., Norrbom J., et al. Human skeletal muscle fibre type variations correlate with PPARα, PPARδ and PGC-1α mRNA. Acta Physiologica 188 (2006) 207-216
125. Franks P.W., Luan J., Browne P.O., et al. Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level?. Metabolism 53 (2004) 11-16
126. Lucia A., Gómez-Gallego F., Barroso I., et al. PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men. J Appl Physiol 99 (2005) 344-348
127. Franks P.W., Barroso I., Luan J., et al. PGC-1alpha genotype modifies the association of volitional energy expenditure with [OV0312]O2max. Med Sci Sports Exerc 35 (2003) 1998-2004
128. Andrulionyte L., Peltola P., Chiasson J.L., et al. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to Type 2 diabetes: the stop-NIDDM trial. Diabetes 55 (2006) 2148-2152
129. Stefan N., Thamer C., Staiger H., et al. Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention. J Clin Endocrinol Metab 92 (2007) 1827-1833
130. Adamo K.B., Sigal R.J., Williams K., et al. Influence of Pro12Ala peroxisome proliferator-activated receptor gamma2 polymorphism on glucose response to exercise training in type 2 diabetes. Diabetologia 48 (2005) 1503-1509
131. Pate R.R., Pratt M., Blair S.N., et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 273 (1995) 402-407
132. Ross R., and Janssen I. Physical activity, total and regional obesity: dose-response considerations. Med Sci Sports Exerc 33 (2001) S521-S529
133. Catenacci V.A., and Wyatt H.R. The role of physical activity in producing and maintaining weight loss. Nature clinical practice. Endocrinology 3 (2007) 518-529
134. Sopko G., Leon A.S., Jacobs Jr. D.R., et al. The effects of exercise and weight loss on plasma lipids in young obese men. Metab Clin Exp 34 (1985) 227-236
135. Ross R., Dagnone D., Jones P.J., et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 133 (2000) 92-103
136. Brooks G.A., Butte N.F., Rand W.M., et al. Chronicle of the Institute of Medicine physical activity recommendation: how a physical activity recommendation came to be among dietary recommendations. Am J Clin Nutr 79 (2004) 921S-930S
137. Saris W.H., Blair S.N., van Baak M.A., et al. How much physical activity is enough to prevent unhealthy weight gain? Outcome of the IASO 1st Stock Conference and consensus statement. Obes Rev 4 (2003) 101-114
138. Praet S.F., and van Loon L.J. Optimizing the therapeutic benefits of exercise in Type 2 diabetes. J Appl Physiol 103 (2007) 1113-1120